385 related articles for article (PubMed ID: 33799644)
21. Ethanol extract of Lithospermum erythrorhizon Sieb. et Zucc. promotes osteoblastogenesis through the regulation of Runx2 and Osterix.
Choi YH; Kim GS; Choi JH; Jin SW; Kim HG; Han Y; Lee DY; Choi SI; Kim SY; Ahn YS; Lee KY; Jeong HG
Int J Mol Med; 2016 Aug; 38(2):610-8. PubMed ID: 27353217
[TBL] [Abstract][Full Text] [Related]
22. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
[TBL] [Abstract][Full Text] [Related]
23. NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC.
Manikandan M; Abuelreich S; Elsafadi M; Alsalman H; Almalak H; Siyal A; Hashmi JA; Aldahmash A; Kassem M; Alfayez M; Mahmood A
Differentiation; 2018; 104():36-41. PubMed ID: 30445268
[TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor α in Osteoblast Differentiation by Stimulating Smad1 Degradation.
Jang WG; Jeong BC; Kim EJ; Choi H; Oh SH; Kim DK; Koo SH; Choi HS; Koh JT
J Biol Chem; 2015 May; 290(21):13556-66. PubMed ID: 25873397
[TBL] [Abstract][Full Text] [Related]
25. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
26. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.
Wang X; Kua HY; Hu Y; Guo K; Zeng Q; Wu Q; Ng HH; Karsenty G; de Crombrugghe B; Yeh J; Li B
J Cell Biol; 2006 Jan; 172(1):115-25. PubMed ID: 16380437
[TBL] [Abstract][Full Text] [Related]
27. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
28. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
29. The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Tormo AJ; Letellier MC; Lissilaa R; Batraville LA; Sharma M; Ferlin W; Elson G; Crabé S; Gauchat JF
Cytokine; 2012 Dec; 60(3):653-60. PubMed ID: 22986012
[TBL] [Abstract][Full Text] [Related]
30. Upregulated osterix expression elicited by Runx2 and Dlx5 is required for the accelerated osteoblast differentiation in PP2A Cα-knockdown cells.
Yang D; Okamura H; Qiu L
Cell Biol Int; 2018 Apr; 42(4):403-410. PubMed ID: 29068100
[TBL] [Abstract][Full Text] [Related]
31. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
32. Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
Xie J; Gu J
J Cell Mol Med; 2015 Aug; 19(8):1814-24. PubMed ID: 25818514
[TBL] [Abstract][Full Text] [Related]
33. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway.
Abdallah BM; Alzahrani AM; Kassem M
Bone; 2018 May; 110():221-229. PubMed ID: 29476977
[TBL] [Abstract][Full Text] [Related]
34. Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation.
Johnson RW; White JD; Walker EC; Martin TJ; Sims NA
Bone; 2014 Jul; 64():47-56. PubMed ID: 24721701
[TBL] [Abstract][Full Text] [Related]
35. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
36. Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation.
Kido S; Kuriwaka-Kido R; Imamura T; Ito Y; Inoue D; Matsumoto T
Bone; 2009 Dec; 45(6):1125-32. PubMed ID: 19665600
[TBL] [Abstract][Full Text] [Related]
37. Cajanolactone A from
Liu S; Luo ZH; Ji GM; Guo W; Cai JZ; Fu LC; Zhou J; Hu YJ; Shen XL
Molecules; 2019 Jan; 24(2):. PubMed ID: 30642055
[TBL] [Abstract][Full Text] [Related]
38. A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization.
Américo-Da-Silva L; Diaz J; Bustamante M; Mancilla G; Oyarzún I; Verdejo HE; Quiroga C
FASEB J; 2018 Sep; 32(9):4681-4695. PubMed ID: 29570393
[TBL] [Abstract][Full Text] [Related]
39. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation.
Liu Y; Bhat RA; Seestaller-Wehr LM; Fukayama S; Mangine A; Moran RA; Komm BS; Bodine PV; Billiard J
Mol Endocrinol; 2007 Feb; 21(2):376-87. PubMed ID: 17095577
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Novel Transcription Factor Required for Osteogenic Differentiation of Mesenchymal Stem Cells.
Querques F; D'Agostino A; Cozzolino C; Cozzuto L; Lombardo B; Leggiero E; Ruosi C; Pastore L
Stem Cells Dev; 2019 Mar; 28(6):370-383. PubMed ID: 30654721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
